← All Sponsors
SPONSOR

Ruth O'Regan

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Breast CancerHER2-positive Breast CancerER Positive Breast CancerPR-Positive Breast Cancer
NCT04886531 Phase 2
Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Breast Cancer
United States View Trial →